Please login to the form below

Not currently logged in
Email:
Password:

Jeff Jonker joins Theravance

He has experience at Genentech
Theravance Jeff Jonker

Theravance has appointed Jeff Jonker as senior VP, corporate and business development.

He joins the US-based biopharma from Satori where he served as chief business officer.

In his new role, he will report to Theravance CEO Rick Winningham and will hold responsibility for managing the company's business and corporate development affairs.

Prior to joining Satori, Jonker held senior roles at Genentech and Gloucester Pharmaceuticals.

"Jeff brings a wealth of industry and deal experience to Theravance,” said Winningham.

The CEO also commented that Jonkers' appointment will support the companys' plans to split into two biotech groups as its deals with GlaxoSmithKline are advanced.

“As Theravance separates into two companies, Jeff's track record of building successful companies and establishing strong collaborations will be important to our future growth,” said Winningham.

4th November 2013

From: Research, Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health

Cello Health’s mission is to help our clients unlock the potential that exists with their assets, brands and organisations in...

Latest intelligence

blood
‘How is your day?’
The initiative that shows how plasma protein therapies improve lives...
women
Advancing women in healthcare
Fostering the next generation of leaders...
The Challenges Of UX In Healthcare: Technology To Change Lives
Blue Latitude Health Director and Head of Customer Experience Elisa Del Galdo explores the latest digital healthcare trends and reveals the innovations changing the sector today....

Infographics